71.24
price up icon2.49%   1.73
pre-market  Vorhandelsmarkt:  72.13   0.89   +1.25%
loading
Schlusskurs vom Vortag:
$69.51
Offen:
$70.46
24-Stunden-Volumen:
1.54M
Relative Volume:
0.84
Marktkapitalisierung:
$12.92B
Einnahmen:
$342.96M
Nettoeinkommen (Verlust:
$-864.29M
KGV:
-12.84
EPS:
-5.55
Netto-Cashflow:
$-636.03M
1W Leistung:
+0.24%
1M Leistung:
-10.86%
6M Leistung:
-3.31%
1J Leistung:
+195.48%
1-Tages-Spanne:
Value
$70.00
$71.95
1-Wochen-Bereich:
Value
$67.66
$72.67
52-Wochen-Spanne:
Value
$21.92
$84.91

Insmed Inc Stock (INSM) Company Profile

Name
Firmenname
Insmed Inc
Name
Telefon
908-977-9900
Name
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Mitarbeiter
1,271
Name
Twitter
@insmed
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
INSM's Discussions on Twitter

Vergleichen Sie INSM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INSM
Insmed Inc
71.24 12.92B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.47 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.49 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.87 36.96B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.75 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
252.77 25.74B 3.81B -644.79M -669.77M -6.24

Insmed Inc Stock (INSM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-25 Eingeleitet RBC Capital Mkts Outperform
2024-04-23 Eingeleitet Truist Buy
2024-02-15 Eingeleitet Wolfe Research Outperform
2023-12-08 Eingeleitet Wells Fargo Overweight
2023-11-20 Fortgesetzt JP Morgan Overweight
2023-07-26 Eingeleitet Guggenheim Buy
2022-12-09 Eingeleitet Mizuho Buy
2022-12-07 Eingeleitet Barclays Overweight
2022-11-18 Eingeleitet BofA Securities Buy
2022-04-27 Eingeleitet Goldman Buy
2021-12-06 Eingeleitet JP Morgan Overweight
2021-10-19 Fortgesetzt Monness Crespi & Hardt Buy
2021-10-19 Fortgesetzt Morgan Stanley Overweight
2021-10-08 Eingeleitet Cantor Fitzgerald Overweight
2021-04-26 Fortgesetzt Credit Suisse Outperform
2020-12-17 Eingeleitet Berenberg Buy
2020-10-12 Fortgesetzt Stifel Buy
2019-09-03 Eingeleitet Goldman Buy
2019-04-09 Bestätigt H.C. Wainwright Buy
2019-02-15 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Hochstufung Goldman Neutral → Buy
2019-01-02 Eingeleitet Canaccord Genuity Buy
2018-08-06 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Eingeleitet Goldman Neutral
2018-04-23 Hochstufung Credit Suisse Neutral → Outperform
2018-03-21 Eingeleitet Morgan Stanley Overweight
2018-01-18 Eingeleitet Credit Suisse Neutral
2017-09-05 Bestätigt Evercore ISI Outperform
2017-08-17 Eingeleitet Evercore ISI Outperform
2017-07-11 Eingeleitet Robert W. Baird Outperform
2016-03-15 Eingeleitet Stifel Buy
2015-11-09 Herabstufung UBS Buy → Neutral
2015-10-06 Bestätigt H.C. Wainwright Buy
2015-06-09 Eingeleitet Citigroup Neutral
2014-03-26 Bestätigt HC Wainwright Buy
Alle ansehen

Insmed Inc Aktie (INSM) Neueste Nachrichten

pulisher
07:00 AM

Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 - Yahoo Finance

07:00 AM
pulisher
Apr 22, 2025

H.C. Wainwright maintains Buy on Insmed stock with $90 target By Investing.com - Investing.com Canada

Apr 22, 2025
pulisher
Apr 17, 2025

Insmed Incorporated (NASDAQ:INSM) Given Average Recommendation of “Buy” by Analysts - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Insmed CEO William Lewis sells $479,176 in stock By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 16, 2025

Insmed CEO William Lewis sells $479,176 in stock - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

New cathepsin C inhibitors disclosed in Insmed patent - BioWorld MedTech

Apr 16, 2025
pulisher
Apr 16, 2025

Envestnet Asset Management Inc. Buys 15,227 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Apr 16, 2025
pulisher
Apr 16, 2025

Wells Fargo & Company MN Buys 33,214 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - MarketScreener

Apr 15, 2025
pulisher
Apr 15, 2025

Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

LPL Financial LLC Raises Position in Insmed Incorporated (NASDAQ:INSM) - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Commit To Purchase Insmed At $50, Earn 13.9% Annualized Using Options - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

Cantor Fitzgerald maintains Overweight on Insmed stock, bullish on TPIP By Investing.com - Investing.com Canada

Apr 11, 2025
pulisher
Apr 08, 2025

Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires? - Insider Monkey

Apr 08, 2025
pulisher
Apr 04, 2025

Form DEF 14A INSMED Inc For: May 15 - StreetInsider

Apr 04, 2025
pulisher
Apr 04, 2025

Insmed CEO William Lewis sells $502,577 in stock By Investing.com - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

Insmed CEO William Lewis sells $502,577 in stock - Investing.com Australia

Apr 03, 2025
pulisher
Apr 02, 2025

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Mar 25, 2025

Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough Data: Insmed's Phase 3 Trial Could Transform Bronchiectasis Treatment - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Wells Fargo Sticks to Their Buy Rating for Insmed (INSM) - The Globe and Mail

Mar 24, 2025
pulisher
Mar 22, 2025

Insmed’s SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada

Mar 22, 2025
pulisher
Mar 22, 2025

Insmed’s SWOT analysis: rare disease biotech stock poised for growth - Investing.com

Mar 22, 2025
pulisher
Mar 20, 2025

Insmed reports preclinical data on INS-1201 for DMD - BioWorld MedTech

Mar 20, 2025
pulisher
Mar 19, 2025

Insmed CEO William Lewis sells $1.97 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Insmed’s stock should triple after positive drug trial data, analyst says - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

H.C. Wainwright maintains Buy on Insmed stock, $90 target By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

Insmed CEO William Lewis sells $1.97 million in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Expert Outlook: Insmed Through The Eyes Of 13 Analysts - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

RBC maintains Outperform on Insmed stock, price target at $100 By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 18, 2025

Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025
pulisher
Mar 15, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

US Bancorp DE Boosts Holdings in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Insider Sell: Roger Adsett Sells 42,975 Shares of Insmed Inc (IN - GuruFocus.com

Mar 11, 2025
pulisher
Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Smartleaf Asset Management LLC - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -March 10, 2025 at 08:01 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Insmed Expands Team with Stock Options Grant to 18 New Hires - StockTitan

Mar 10, 2025
pulisher
Mar 08, 2025

UBS Group Raises Insmed (NASDAQ:INSM) Price Target to $110.00 - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Insmed’s Strategic Growth and Promising Pipeline Drive Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

UBS raises Insmed stock price target to $110 By Investing.com - Investing.com UK

Mar 06, 2025

Finanzdaten der Insmed Inc-Aktie (INSM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Insmed Inc-Aktie (INSM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Lewis William
Chair and CEO
Apr 15 '25
Sale
70.16
6,830
479,177
233,924
$20.27
price up icon 1.00%
$32.19
price up icon 0.00%
$27.35
price up icon 8.45%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.27%
Kapitalisierung:     |  Volumen (24h):